Literature DB >> 17079050

Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity.

A Christy Hunter1.   

Abstract

Synthetic polymer based Polyfectins (cationic polymer-DNA complex) have received intensive scientific research as they can potentially circumvent problems associated with viral vectors for gene therapy. These cationic macromolecules can readily condense DNA or RNA into stable nanostructures for use in gene delivery. Recently two commonly used polycations, poly(ethylenimine) (PEI) and poly(L-lysine) have demonstrated their ability to induce apoptosis in a range of human cell lines. This may be the explanation for short-term gene transfection observed with polyfectins. It is the aim of this review to discuss these and other factors behind observed toxicities including the inherent polydisperse nature of polymeric macromolecules and their behaviour in vivo. Strategies for reduction of toxicity are included such as new polymeric synthetic technologies and vector pegylation. There is a clear and immediate need for understanding of the mechanisms which cause polyfectin toxicity which will ultimately facilitate improved vector design and safer gene delivery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17079050     DOI: 10.1016/j.addr.2006.09.008

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  95 in total

1.  Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.

Authors:  Hyun-Jong Cho; Saeho Chong; Suk-Jae Chung; Chang-Koo Shim; Dae-Duk Kim
Journal:  Pharm Res       Date:  2011-12-15       Impact factor: 4.200

2.  Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine.

Authors:  Shanta Raj Bhattarai; Elayaraja Muthuswamy; Amit Wani; Michal Brichacek; Antonio L Castañeda; Stephanie L Brock; David Oupicky
Journal:  Pharm Res       Date:  2010-08-21       Impact factor: 4.200

3.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.

Authors:  Hyejung Mok; Omid Veiseh; Chen Fang; Forrest M Kievit; Freddy Y Wang; James O Park; Miqin Zhang
Journal:  Mol Pharm       Date:  2010-09-14       Impact factor: 4.939

4.  Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells.

Authors:  Kun Ma; Duo Fu; Dongli Yu; Changhao Cui; Li Wang; Zhaoming Guo; Chuanbin Mao
Journal:  Biomaterials       Date:  2017-01-02       Impact factor: 12.479

5.  Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents.

Authors:  Volker Mailänder; Myriam Ricarda Lorenz; Verena Holzapfel; Anna Musyanovych; Karin Fuchs; Markus Wiesneth; Paul Walther; Katharina Landfester; Hubert Schrezenmeier
Journal:  Mol Imaging Biol       Date:  2008-02-23       Impact factor: 3.488

6.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

7.  Maximizing gene delivery efficiencies of cationic helical polypeptides via balanced membrane penetration and cellular targeting.

Authors:  Nan Zheng; Lichen Yin; Ziyuan Song; Liang Ma; Haoyu Tang; Nathan P Gabrielson; Hua Lu; Jianjun Cheng
Journal:  Biomaterials       Date:  2013-11-07       Impact factor: 12.479

8.  Recombinant collagen for animal product-free dextran microcarriers.

Authors:  Michael K Dame; James Varani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-09-25       Impact factor: 2.416

9.  A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.

Authors:  Omid Veiseh; Forrest M Kievit; Jonathan W Gunn; Buddy D Ratner; Miqin Zhang
Journal:  Biomaterials       Date:  2008-11-05       Impact factor: 12.479

10.  Synthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene delivery.

Authors:  Rob S Burke; Suzie H Pun
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.